JP2009532413A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009532413A5 JP2009532413A5 JP2009503532A JP2009503532A JP2009532413A5 JP 2009532413 A5 JP2009532413 A5 JP 2009532413A5 JP 2009503532 A JP2009503532 A JP 2009503532A JP 2009503532 A JP2009503532 A JP 2009503532A JP 2009532413 A5 JP2009532413 A5 JP 2009532413A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- optionally
- cycloalkyl
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 20
- 229910052739 hydrogen Inorganic materials 0.000 claims 14
- 239000001257 hydrogen Substances 0.000 claims 11
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 6
- 150000002431 hydrogen Chemical class 0.000 claims 6
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 206010006451 bronchitis Diseases 0.000 claims 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000005842 heteroatom Chemical group 0.000 claims 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 3
- 208000029523 Interstitial Lung disease Diseases 0.000 claims 3
- 230000000172 allergic effect Effects 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000003003 spiro group Chemical group 0.000 claims 3
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 2
- 206010001889 Alveolitis Diseases 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 239000005557 antagonist Substances 0.000 claims 2
- -1 aryl-C 1-6 -alkyl Chemical group 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 208000010668 atopic eczema Diseases 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 201000001155 extrinsic allergic alveolitis Diseases 0.000 claims 2
- 208000022098 hypersensitivity pneumonitis Diseases 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 125000004434 sulfur atom Chemical group 0.000 claims 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- 206010052613 Allergic bronchitis Diseases 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 206010006458 Bronchitis chronic Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010009137 Chronic sinusitis Diseases 0.000 claims 1
- 208000027932 Collagen disease Diseases 0.000 claims 1
- 206010011224 Cough Diseases 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 206010014561 Emphysema Diseases 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 208000000592 Nasal Polyps Diseases 0.000 claims 1
- 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 claims 1
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 claims 1
- 229940123932 Phosphodiesterase 4 inhibitor Drugs 0.000 claims 1
- 206010037423 Pulmonary oedema Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 201000009594 Systemic Scleroderma Diseases 0.000 claims 1
- 206010042953 Systemic sclerosis Diseases 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000000808 adrenergic beta-agonist Substances 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 208000006682 alpha 1-Antitrypsin Deficiency Diseases 0.000 claims 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 claims 1
- 229940125715 antihistaminic agent Drugs 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 230000003454 betamimetic effect Effects 0.000 claims 1
- 201000009267 bronchiectasis Diseases 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 208000029771 childhood onset asthma Diseases 0.000 claims 1
- 239000000812 cholinergic antagonist Substances 0.000 claims 1
- 208000007451 chronic bronchitis Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 claims 1
- 239000003246 corticosteroid Substances 0.000 claims 1
- 229960001334 corticosteroids Drugs 0.000 claims 1
- 229940052760 dopamine agonists Drugs 0.000 claims 1
- 239000003136 dopamine receptor stimulating agent Substances 0.000 claims 1
- 239000000890 drug combination Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 229940121647 egfr inhibitor Drugs 0.000 claims 1
- 244000000013 helminth Species 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 230000036571 hydration Effects 0.000 claims 1
- 238000006703 hydration reaction Methods 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- YEESKJGWJFYOOK-IJHYULJSSA-N leukotriene D4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@H](N)C(=O)NCC(O)=O YEESKJGWJFYOOK-IJHYULJSSA-N 0.000 claims 1
- 206010025135 lupus erythematosus Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 208000016366 nasal cavity polyp Diseases 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 208000037916 non-allergic rhinitis Diseases 0.000 claims 1
- 230000007170 pathology Effects 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 239000002935 phosphatidylinositol 3 kinase inhibitor Substances 0.000 claims 1
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 claims 1
- 208000005333 pulmonary edema Diseases 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 201000000306 sarcoidosis Diseases 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
- 230000002588 toxic effect Effects 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
- 0 **N(*)C(*)=O Chemical compound **N(*)C(*)=O 0.000 description 16
- YDKNASMIEZGJEJ-UHFFFAOYSA-N NN(CC1)CCS1(=O)=O Chemical compound NN(CC1)CCS1(=O)=O YDKNASMIEZGJEJ-UHFFFAOYSA-N 0.000 description 1
- DOJXXICCKPTQFE-UHFFFAOYSA-N NN(CC1)CCS1=O Chemical compound NN(CC1)CCS1=O DOJXXICCKPTQFE-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06112300 | 2006-04-06 | ||
| EP06112300.6 | 2006-04-06 | ||
| PCT/EP2007/052912 WO2007115929A1 (de) | 2006-04-06 | 2007-03-27 | Thiazolyl-dihydro-quinazoline |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009532413A JP2009532413A (ja) | 2009-09-10 |
| JP2009532413A5 true JP2009532413A5 (enExample) | 2010-06-03 |
| JP5303450B2 JP5303450B2 (ja) | 2013-10-02 |
Family
ID=36790884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009503532A Expired - Fee Related JP5303450B2 (ja) | 2006-04-06 | 2007-03-27 | チアゾリル−ジヒドロキナゾリン |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US7691868B2 (enExample) |
| EP (1) | EP2018385B1 (enExample) |
| JP (1) | JP5303450B2 (enExample) |
| KR (1) | KR20090029181A (enExample) |
| CN (2) | CN101460505B (enExample) |
| AR (1) | AR060269A1 (enExample) |
| AU (1) | AU2007236043B2 (enExample) |
| BR (1) | BRPI0710575A2 (enExample) |
| CA (1) | CA2647056A1 (enExample) |
| DK (1) | DK2018385T3 (enExample) |
| ES (1) | ES2425051T3 (enExample) |
| IL (1) | IL194490A0 (enExample) |
| MX (1) | MX2008011957A (enExample) |
| NZ (1) | NZ572508A (enExample) |
| RU (1) | RU2008143546A (enExample) |
| TW (1) | TW200804402A (enExample) |
| WO (1) | WO2007115929A1 (enExample) |
| ZA (1) | ZA200807349B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070238746A1 (en) * | 2006-04-06 | 2007-10-11 | Trixi Brandl | Thiazolyl-dihydro-chinazoline |
| US7691868B2 (en) | 2006-04-06 | 2010-04-06 | Boehringer Ingelheim International Gmbh | Thiazolyl-dihydro-quinazoline |
| US20070259855A1 (en) * | 2006-04-06 | 2007-11-08 | Udo Maier | Thiazolyl-dihydro-indazole |
| JPWO2010024258A1 (ja) * | 2008-08-29 | 2012-01-26 | 塩野義製薬株式会社 | Ｐｉ３ｋ阻害活性を有する縮環アゾール誘導体 |
| TW201103943A (en) * | 2009-04-27 | 2011-02-01 | Shionogi & Co | Urea derivative having pi3k inhibitory activity |
| KR20120046723A (ko) * | 2009-07-02 | 2012-05-10 | 노파르티스 아게 | Ｐｉ３ｋ 억제제로서 유용한 2-카르복스아미드 시클로아미노 우레아 |
| US11633399B2 (en) | 2018-12-25 | 2023-04-25 | Sol-Gel Technologies Ltd. | Treatment of skin disorders with compositions comprising an EGFR inhibitor |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US259855A (en) * | 1882-06-20 | Fbank s | ||
| US244104A (en) * | 1881-07-12 | andrews | ||
| US238718A (en) * | 1881-03-08 | Efeico eosenzi | ||
| US238730A (en) * | 1881-03-08 | Wagon-brake | ||
| US4380640A (en) * | 1980-01-21 | 1983-04-19 | Ciba-Geigy Corporation | Novel benzthiazolylurea derivatives, compositions containing them and their use as herbicides |
| AU2001236698A1 (en) * | 2000-02-07 | 2001-08-14 | Abbott Gesellschaft Mit Beschrankter Haftung & Company Kommanditgesellschaft | 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| US20040009613A1 (en) * | 2001-02-16 | 2004-01-15 | Ming-Ming Zhou | Methods of identifying modulators of bromodomains |
| US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| AR038703A1 (es) | 2002-02-28 | 2005-01-26 | Novartis Ag | Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3 |
| US7846925B2 (en) | 2002-07-10 | 2010-12-07 | Merck Serono Sa | Azolidinone-vinyl fused-benzene derivatives |
| PT2042504E (pt) | 2002-09-30 | 2011-09-07 | Bayer Schering Pharma Ag | Derivados da azolepirimidina fundida |
| WO2004052373A1 (en) | 2002-12-06 | 2004-06-24 | Warner-Lambert Company Llc | Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k |
| AU2003303231A1 (en) | 2002-12-20 | 2004-07-14 | Warner-Lambert Company Llc | Benzoxazines and derivatives thereof as inhibitors of pi3ks |
| RU2006100484A (ru) | 2003-06-13 | 2006-06-10 | Центарис ГмбХ, Германи (DE) | Соединения, обладающие ингибирующей активностью в отношении фосфатидилинозит-3-киназы, фармацевтическая композиция, способ определения эффективности этих соединений, способ лечения нарушений (варианты) и способ изменения передачи сигнала в клетках |
| GB0315966D0 (en) | 2003-07-08 | 2003-08-13 | Cyclacel Ltd | Compounds |
| CN1897950A (zh) | 2003-10-14 | 2007-01-17 | 惠氏公司 | 稠合芳基和杂芳基衍生物及其使用方法 |
| UY29149A1 (es) | 2004-10-07 | 2006-05-31 | Boehringer Ingelheim Int | Tiazolil-dihidro-indazoles |
| AU2005293607A1 (en) | 2004-10-07 | 2006-04-20 | Boehringer Ingelheim International Gmbh | PI3 kinases |
| US20070238746A1 (en) * | 2006-04-06 | 2007-10-11 | Trixi Brandl | Thiazolyl-dihydro-chinazoline |
| US20070259855A1 (en) | 2006-04-06 | 2007-11-08 | Udo Maier | Thiazolyl-dihydro-indazole |
| US7517995B2 (en) | 2006-04-06 | 2009-04-14 | Boehringer Ingelheim International Gmbh | Thiazolyl-dihydro-cyclopentapyrazole |
| US7691868B2 (en) | 2006-04-06 | 2010-04-06 | Boehringer Ingelheim International Gmbh | Thiazolyl-dihydro-quinazoline |
| US20070238718A1 (en) | 2006-04-06 | 2007-10-11 | Matthias Grauert | Thiazolyl-dihydro-indazole |
-
2007
- 2007-03-23 US US11/690,362 patent/US7691868B2/en active Active
- 2007-03-27 RU RU2008143546/04A patent/RU2008143546A/ru not_active Application Discontinuation
- 2007-03-27 JP JP2009503532A patent/JP5303450B2/ja not_active Expired - Fee Related
- 2007-03-27 KR KR1020087027076A patent/KR20090029181A/ko not_active Ceased
- 2007-03-27 CN CN2007800207880A patent/CN101460505B/zh not_active Expired - Fee Related
- 2007-03-27 CN CN201310049412XA patent/CN103172589A/zh active Pending
- 2007-03-27 MX MX2008011957A patent/MX2008011957A/es active IP Right Grant
- 2007-03-27 NZ NZ572508A patent/NZ572508A/en not_active IP Right Cessation
- 2007-03-27 BR BRPI0710575-4A patent/BRPI0710575A2/pt not_active IP Right Cessation
- 2007-03-27 ES ES07727385T patent/ES2425051T3/es active Active
- 2007-03-27 EP EP07727385.2A patent/EP2018385B1/de not_active Not-in-force
- 2007-03-27 WO PCT/EP2007/052912 patent/WO2007115929A1/de not_active Ceased
- 2007-03-27 DK DK07727385.2T patent/DK2018385T3/da active
- 2007-03-27 AU AU2007236043A patent/AU2007236043B2/en not_active Ceased
- 2007-03-27 CA CA002647056A patent/CA2647056A1/en not_active Abandoned
- 2007-04-03 AR ARP070101387A patent/AR060269A1/es unknown
- 2007-04-04 TW TW096111946A patent/TW200804402A/zh unknown
-
2008
- 2008-08-26 ZA ZA200807349A patent/ZA200807349B/xx unknown
- 2008-10-02 IL IL194490A patent/IL194490A0/en unknown
-
2010
- 2010-02-17 US US12/706,936 patent/US8334378B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009532417A5 (enExample) | ||
| JP2008515852A5 (enExample) | ||
| JP2009532413A5 (enExample) | ||
| ES2292988T3 (es) | Derivados de nicotinamida utiles como inhibidores de pde4. | |
| JP2014534222A5 (enExample) | ||
| JP2011530493A5 (enExample) | ||
| JP6120951B2 (ja) | 新規ｅｐ２受容体作動薬 | |
| CA2471578A1 (en) | Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments | |
| RU2007116861A (ru) | P13-киназы | |
| TW200630346A (en) | Pyrimidines as prostaglandin D2 receptor antagonists | |
| CA2472149A1 (en) | New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments | |
| JP2011507878A5 (enExample) | ||
| JP2013539780A (ja) | Ｐｉ３キナーゼ阻害剤として使用するキナゾリン−４（３ｈ）−オン誘導体 | |
| JP2010540593A5 (enExample) | ||
| JP2009534405A5 (enExample) | ||
| ES2786374T3 (es) | Compuesto antimicótico | |
| RU2008143548A (ru) | Тиазолилдигидрохиназолины | |
| RU2007101236A (ru) | Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей | |
| RU2008143557A (ru) | Тиазолилдигидроиндазолы | |
| HRP20171614T1 (hr) | Heterociklički spojevi, lijekovi koji sadrže te spojeve, njihova primjena i postupci za njihovu proizvodnju | |
| RU2008143547A (ru) | Тиазолилдигидроциклопентапиразолы для применения в качестве ингибиторов pi3-киназы | |
| HRP20120869T1 (hr) | Spirocikliäśki heterocikli, lijekovi koji sadrže te spojeve, njihova uporaba te postupak njihove proizvodnje | |
| RU2008143552A (ru) | Тиазолилдигидроиндазолы | |
| RU2008129620A (ru) | Пиразиноилгуанидиновые соединения, применяемые в лечении воспалительных или аллергических заболеваний | |
| JP2012505879A5 (enExample) |